Ionis Pharmaceuticals Shares Plunge After GASK Decided Not To Initiate Phase Trial Outcome On TTRRx
May 26, 2016 at 11:23 AM EDT
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) provided an update on its IONIS-TTRRx program. The company is evaluating IONIS-TTRRx in an ...